2Norman MG. Sponsor Agreements with Research Sites and CROs [EB/OL]. [2013-01-12]. http://firstclinical.com/ journal/2008~0811 _Contract_Differences.pdf.
6CFDA,Notice on asking for suggestions for “Drug registration management approach”ammendment[ED/QL]. [2014-12-29]2013-11-12. http://www.sda.gov.cn/WS01/CL0778/94158.html.
7FENG D L. CPPCC proposal of China should put into practice of MAH[ED/QL]. [2014-12-29]2013-03-05. http://money. 163. com/13/0305/20/8P7RRSO900254T7L. html.
8LIU Y C,DONG J P. Research on the status quo of orphan drug management[J]. 中国药学杂志,2012,47(5):395-397.
